Amphenol
APH
80.28
+0.93
+1.17%
Amphenol
US · APH
#90 by market cap
Listed 1970
80.28
+0.93
+1.17%
Live - 5344 symbols - heartbeat 58s ago
· 2026-10-20 06:39
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 7.23, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +51.71% YoY
Margins
- Gross margin
- 36.88%
- Operating margin
- 25.86%
- Net margin
- 18.49%
Key ratios & quality
- Enterprise valuei
- 202.04B
- PEG ratioi
- 1.30
- Altman Z-Scorei
- 7.23
PEG uses trailing P/E against the 3-year net income growth rate (30.94%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 8.20B | 8.23B | 8.60B | 10.88B | 12.62B | 12.55B | 15.22B | 23.09B |
| Gross profit | 2.65B | 2.62B | 2.66B | 3.40B | 4.03B | 4.08B | 5.14B | 8.52B |
| Selling & admin expenses | 959.50M | 971.40M | 1.01B | 1.23B | 1.42B | 1.49B | 1.86B | 2.55B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.70B | 1.64B | 1.65B | 2.18B | 2.61B | 2.59B | 3.28B | 5.97B |
| Pretax profit | 1.59B | 1.50B | 1.53B | 1.99B | 2.47B | 2.45B | 3.01B | 5.60B |
| Tax | 371.50M | 331.90M | 313.30M | 409.10M | 550.60M | 509.30M | 570.30M | 1.30B |
| Net profit | 1.22B | 1.16B | 1.21B | 1.60B | 1.92B | 1.95B | 2.44B | 4.31B |
| Basic EPS | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 2 |
| Diluted EPS | 0.48 | 0.47 | 0.49 | 0.64 | 0.77 | 0.78 | 0.96 | 1.67 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 4.81B | 5.65B | 6.19B | 6.44B | 7.62B | 8.76B |
| Gross profit | 1.64B | 2.05B | 2.36B | 2.46B | 2.80B | 3.55B |
| Selling & admin expenses | 575.20M | 622.50M | 657.00M | 691.00M | 851.50M | 939.90M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.07B | 1.43B | 1.70B | 1.77B | 1.95B | 2.61B |
| Pretax profit | 962.90M | 1.35B | 1.64B | 1.65B | 1.65B | 2.39B |
| Tax | 218.70M | 247.30M | 385.80M | 443.60M | 702.40M | 604.30M |
| Net profit | 744.20M | 1.10B | 1.26B | 1.21B | 943.30M | 1.78B |
| Basic EPS | 0 | 0 | 1 | 0 | 0 | 1 |
| Diluted EPS | 0.29 | 0.43 | 0.49 | 0.47 | 0.36 | 0.69 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 4.57B | 4.21B | 5.49B | 5.96B | 6.48B | 6.84B | 9.69B | 20.27B |
| Cash & ST investments | 1.29B | 908.60M | 1.74B | 1.24B | 1.43B | 1.66B | 3.34B | 11.43B |
| Inventory | 1.23B | 1.31B | 1.46B | 1.89B | 2.09B | 2.17B | 2.55B | 3.42B |
| Total assets | 10.04B | 10.82B | 12.33B | 14.68B | 15.33B | 16.53B | 21.44B | 36.24B |
| Total current liabilities | 2.45B | 2.13B | 2.30B | 2.45B | 2.68B | 3.15B | 4.08B | 6.80B |
| Short-term debt | 764.30M | 403.30M | 230.30M | 4.00M | 2.70M | 353.80M | 401.70M | 937.20M |
| Long-term debt | 2.81B | 3.20B | 3.64B | 4.80B | 4.58B | 3.98B | 6.48B | 14.56B |
| Total liabilities | 5,980,700,000.00 | 6,219,300,000.00 | 6,875,400,000.00 | 8,299,300,000.00 | 8,232,100,000.00 | 8,099,900,000.00 | 11,584,100,000.00 | 22,727,200,000.00 |
| Total equity | 4.06B | 4.60B | 5.45B | 6.38B | 7.09B | 8.43B | 9.86B | 13.51B |
| Retained earnings | 3.03B | 3.35B | 3.71B | 4.28B | 4.98B | 5.92B | 7.11B | 9.85B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 9.13B | 11.30B | 12.38B | 20.27B | 15.38B | 17.82B |
| Cash & ST investments | 1.67B | 3.23B | 3.89B | 11.43B | 4.58B | 5.42B |
| Inventory | 2.91B | 3.14B | 3.30B | 3.42B | 4.09B | 4.55B |
| Total assets | 22.90B | 25.67B | 27.14B | 36.24B | 42.13B | 44.81B |
| Total current liabilities | 4.59B | 5.60B | 5.98B | 6.80B | 8.97B | 9.44B |
| Short-term debt | 350.80M | 936.60M | 937.60M | 937.20M | 2.11B | 1.63B |
| Long-term debt | 6.82B | 7.13B | 7.13B | 14.56B | 16.64B | 17.18B |
| Total liabilities | 12,529,700,000.00 | 14,068,700,000.00 | 14,536,100,000.00 | 22,727,200,000.00 | 28,042,300,000.00 | 29,184,500,000.00 |
| Total equity | 10.37B | 11.60B | 12.61B | 13.51B | 14.09B | 15.62B |
| Retained earnings | 7.45B | 8.14B | 9.16B | 9.85B | 10.43B | 11.64B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.11B | 1.50B | 1.59B | 1.54B | 2.17B | 2.53B | 2.81B | 5.37B |
| Depreciation & amortization | 299.70M | 312.10M | 308.10M | 395.60M | 392.90M | 406.40M | 572.50M | 922.40M |
| Free cash flow | 802.10M | 1.21B | 1.32B | 1.18B | 1.79B | 2.16B | 2.15B | 4.38B |
| Dividends paid | -253.70M | -279.50M | -297.60M | -346.70M | -477.40M | -500.60M | -595.10M | -802.20M |
| Stock buybacks / issuance | -935.20M | -601.70M | -641.30M | -661.70M | -730.50M | -585.10M | -689.30M | -753.20M |
| Ending cash balance | 1.28B | 891.20M | 1.70B | 1.20B | 1.37B | 1.48B | 3.32B | 11.13B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 764.90M | 1.42B | 1.47B | 1.72B | 1.12B | 1.56B |
| Depreciation & amortization | 236.30M | 209.40M | 227.70M | 249.00M | 485.80M | 341.40M |
| Free cash flow | 576.30M | 1.12B | 1.21B | 1.47B | 829.90M | 1.20B |
| Dividends paid | -199.50M | -199.60M | -201.20M | -201.90M | -306.70M | -307.30M |
| Stock buybacks / issuance | -180.90M | -160.10M | -152.90M | -259.30M | -178.00M | -208.00M |
| Ending cash balance | 1.66B | 3.21B | 3.80B | 11.13B | 4.13B | 4.73B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 30.10 | 27.03 | 24.27 | 27.22 | 28.57 | 25.10 | 26.73 | 36.80 |
| ROA %i | 12.02 | 11.07 | 10.40 | 11.78 | 12.68 | 12.11 | 12.77 | 14.81 |
| ROIC %i | 16.97 | 15.85 | 14.90 | 16.53 | 17.64 | 16.79 | 17.71 | 19.97 |
| 5-year avg ROE %i | 24.06 | 24.55 | 24.44 | 25.12 | 27.44 | 26.44 | 26.38 | 28.89 |
| EBIT margin %i | 20.61 | 19.62 | 19.10 | 19.35 | 20.56 | 20.66 | 21.21 | 25.84 |
| FCF / sales %i | 9.78 | 14.68 | 15.30 | 10.85 | 14.19 | 17.17 | 14.12 | 18.96 |
| Current ratioi | 1.86 | 1.97 | 2.38 | 2.43 | 2.42 | 2.17 | 2.37 | 2.98 |
| Quick ratioi | 1.26 | 1.24 | 1.60 | 1.51 | 1.52 | 1.36 | 1.62 | 2.37 |
| Debt / assetsi | 35.55 | 33.35 | 31.37 | 32.70 | 29.87 | 26.24 | 32.12 | 42.78 |
| LT debt / equityi | 69.86 | 70.71 | 67.53 | 76.10 | 65.21 | 47.73 | 66.22 | 108.59 |
| Interest coveragei | 16.62 | 13.72 | 14.23 | 18.22 | 20.22 | 18.60 | 14.88 | 16.23 |
| Revenue CAGR (3Y) %i | 13.78 | 9.38 | 7.04 | 9.86 | 15.35 | 13.45 | 11.86 | 22.31 |
| Net income CAGR (3Y) %i | 16.43 | 11.96 | 22.76 | 9.70 | 18.10 | 17.01 | 15.07 | 30.94 |
| FCF CAGR (3Y) %i | -2.24 | 10.83 | 12.75 | 13.72 | 14.05 | 17.91 | 22.14 | 34.71 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 27.53 | 31.02 | 34.78 | 36.80 | 36.79 | 38.08 |
| ROA %i | 13.19 | 14.37 | 16.35 | 14.81 | 13.73 | 14.60 |
| ROIC %i | 18.49 | 20.02 | 22.87 | 19.97 | 19.22 | 20.75 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 21.26 | 22.72 | 24.64 | 25.84 | 26.18 | 27.42 |
| FCF / sales %i | 13.23 | 14.97 | 16.96 | 18.96 | 17.88 | 16.25 |
| Current ratioi | 1.99 | 2.02 | 2.07 | 2.98 | 1.71 | 1.89 |
| Quick ratioi | 1.22 | 1.34 | 1.41 | 2.37 | 1.17 | 1.29 |
| Debt / assetsi | 31.29 | 31.41 | 29.72 | 42.78 | 44.50 | 41.98 |
| LT debt / equityi | 66.17 | 61.86 | 56.94 | 108.59 | 119.05 | 110.88 |
| Interest coveragei | 13.97 | 15.27 | 16.94 | 16.23 | 13.59 | 12.59 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Communications Solutions is the largest reported line at 61.97% of revenue, across 4 reported segments.
- Harsh Environment Solutions follows at 21.67%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Communications Solutions61.97%
Harsh Environment Solutions21.67%
Interconnect and Sensor Systems17.66%
Quote time 2026-10-20 06:39:27 · For reference only, not investment advice and not tailored to your situation.
Amphenol discussion 0 comments